Sign in
4

Changes in Ownership

ArriVent BioPharma, Inc. Filed Acc 0001104659-25-061268

Options or other derivatives

  • Director acquired 15,502 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hohneker John Director 2025-06-18 Grant or award · Non-Qualified Stock Option (right to buy) +15,502 15,502 D: show line 1 in the form
Loading xslF345X05/tm2518583-2_4seq1.xml…